Long Noncoding RNAs as Diagnostic and Therapeutic Targets for Ischemic Stroke

Area of Science:

• Biochemistry
• Molecular Biology
• Neuroscience

Background:

• Long non-coding RNAs (lncRNAs) are non-protein-coding endogenous molecules.
• LncRNAs are increasingly recognized as key regulators in ischemic stroke.
• Their roles extend to associated conditions like atherosclerosis, dyslipidemia, hypertension, and diabetes mellitus.

Purpose of the Study:

• To review recent advancements in lncRNA-based therapeutics for ischemic diseases.
• To summarize the current knowledge on lncRNAs in ischemic stroke.
• To highlight the regulatory functions, biomarker potential, and therapeutic applications of lncRNAs in cerebral ischemia.

Main Methods:

• Literature review of recent studies on lncRNAs and ischemic stroke.
• Analysis of lncRNA expression patterns in various ischemic stroke models and patient samples.
• Synthesis of information on the functional roles and therapeutic potential of lncRNAs.

Main Results:

• Altered lncRNA expression is observed in rodent models, cell cultures, and human stroke patients.
• LncRNAs are implicated in the pathogenesis of ischemic stroke and related conditions.
• LncRNAs show promise as diagnostic and prognostic biomarkers for cerebral ischemia.

Conclusions:

• LncRNAs are vital regulators of ischemic stroke pathogenesis.
• LncRNAs represent promising biomarkers for diagnosing and predicting outcomes in cerebral ischemia.
• LncRNA-based strategies offer potential new therapeutic avenues for treating ischemic stroke.